For decades, marketers have relied on the global research giants to track the health of their brands.
They offered global infrastructure and promised comparability between markets; they provided the credibility that reassured multinational corporations.
However, they had blind spots that have grown more costly over time.
๐๐ถ๐ฟ๐๐, they were largely descriptive and backwardโlooking, telling teams what moved last month without isolating what mattered or forecasting what would happen next.
๐ฆ๐ฒ๐ฐ๐ผ๐ป๐ฑ, the proliferation of โalwaysโonโ monitoring tools created the opposite problem: statistical noise was interpreted as signals, prompting teams to โdo somethingโ when the smartest action was often to do nothing.
๐ง๐ต๐ถ๐ฟ๐ฑ, episodic brand valuation exercises left operating teams guessing about what to change in market.
๐๐ถ๐ป๐ฎ๐น๐น๐, internally developed scorecards rarely traveled well across functions.
The result is an organization that measures a lot yet still asks the same question quarter after quarter:
๐๐ฉ๐ข๐ต ๐ด๐ฑ๐ฆ๐ค๐ช๐ง๐ช๐ค ๐ฎ๐ฐ๐ท๐ฆ ๐ธ๐ช๐ญ๐ญ ๐ค๐ณ๐ฆ๐ข๐ต๐ฆ ๐ต๐ฉ๐ฆ ๐ฎ๐ฐ๐ด๐ต ๐ท๐ข๐ญ๐ถ๐ฆ? Familiar problems? Letโs talk about the ๐ ๐ฆ๐ช ๐๐ฟ๐ฎ๐ป๐ฑ ๐๐ฑ๐๐ฎ๐ป๐๐ฎ๐ด๐ฒ ๐ฆ๐ผ๐น๐๐๐ถ๐ผ๐ป to fix them.
